Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Clinical Pharmacology and Therapeutics
|
July 1, 1991
Exploratory analysis of population pharmacokinetic data from clinical trials with application to isradipine
R Laplanche, B Fertil, E Nüesch, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 12, 2001
Role of modelling and simulation in Phase I drug development
L Aarons, M O Karlsson, F Mentré, et al.
International Journal of Bio-Medical Computing
|
August 1, 1979
A non-linear mathematical model for the in vivo determination of Kupffer cells number and rate of phagocytosis of radiocolloids in rats
J F Boisvieux, J L Steimer, A Venot, et al.
Clinical Pharmacology and Therapeutics
|
December 30, 2011
Pharmacokinetic similarity of biologics: analysis using nonlinear mixed-effects modeling
A Dubois, S Gsteiger, S Balser, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 10, 2013
Modeling and simulation to optimize the design and analysis of confirmatory trials, characterize risk-benefit, and support label claims
S F Marshall, R Hemmings, F Josephson, et al.
Clinical Pharmacokinetics
|
February 1, 1996
The use of population pharmacokinetics in drug development
S Vozeh, J L Steimer, M Rowland, et al.
L'Encephale
|
January 1, 1984
[Renal clearance technic for individualizing lithium dosage in routine hospital care]
E Klinger, J L Steimer, R Jouvent, et al.
The Journal of Biological Chemistry
|
January 10, 1981
Effect of adrenalectomy and aldosterone on the modulation of mineralocorticoid receptors in rat kidney
M Claire, M E Oblin, J L Steimer, et al.
Clinical Pharmacokinetics
|
August 1, 1997
An evaluation of the integration of pharmacokinetic and pharmacodynamic principles in clinical drug development. Experience within Hoffmann La Roche
B G Reigner, P E Williams, I H Patel, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
October 20, 2006
Modelling response time profiles in the absence of drug concentrations: definition and performance evaluation of the K-PD model
P Jacqmin, E Snoeck, E A van Schaick, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Clinical Pharmacology and Therapeutics
|
July 1, 1991
Exploratory analysis of population pharmacokinetic data from clinical trials with application to isradipine
R Laplanche, B Fertil, E Nüesch, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 12, 2001
Role of modelling and simulation in Phase I drug development
L Aarons, M O Karlsson, F Mentré, et al.
International Journal of Bio-Medical Computing
|
August 1, 1979
A non-linear mathematical model for the in vivo determination of Kupffer cells number and rate of phagocytosis of radiocolloids in rats
J F Boisvieux, J L Steimer, A Venot, et al.
Clinical Pharmacology and Therapeutics
|
December 30, 2011
Pharmacokinetic similarity of biologics: analysis using nonlinear mixed-effects modeling
A Dubois, S Gsteiger, S Balser, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 10, 2013
Modeling and simulation to optimize the design and analysis of confirmatory trials, characterize risk-benefit, and support label claims
S F Marshall, R Hemmings, F Josephson, et al.
Clinical Pharmacokinetics
|
February 1, 1996
The use of population pharmacokinetics in drug development
S Vozeh, J L Steimer, M Rowland, et al.
L'Encephale
|
January 1, 1984
[Renal clearance technic for individualizing lithium dosage in routine hospital care]
E Klinger, J L Steimer, R Jouvent, et al.
The Journal of Biological Chemistry
|
January 10, 1981
Effect of adrenalectomy and aldosterone on the modulation of mineralocorticoid receptors in rat kidney
M Claire, M E Oblin, J L Steimer, et al.
Clinical Pharmacokinetics
|
August 1, 1997
An evaluation of the integration of pharmacokinetic and pharmacodynamic principles in clinical drug development. Experience within Hoffmann La Roche
B G Reigner, P E Williams, I H Patel, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
October 20, 2006
Modelling response time profiles in the absence of drug concentrations: definition and performance evaluation of the K-PD model
P Jacqmin, E Snoeck, E A van Schaick, et al.
Page
of 5